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Coronary heart disease (CHD) is the
leading cause of death in the Netherlands, as
in the rest of the world.' The costs for CHD
are increasing rapidly, faster than medical
costs for other causes in the Netherlands.2
Part of this increase seems to be the result of
expanding health care needs. Mortality rates
are declining steeply, but hospital admission
rates are increasing.3 As more patients sur-
vive acute myocardial infarction, more are
eligible for intervention or remain at risk for
recurrent infarction or congestive heart
failure.4
In this study we estimated the changing
prevalence of CHD as a consequence of the
changing disease history. An incidence-
prevalence-mortality model describes a sim-
plified CHD history: flows of incidence and
mortality determine pools of surviving
patients.5 We will show that the decreasing
CHD mortality is causing hospital admission
rates to rise and quantify the resulting
marked increase in the prevalence of sur-
vivors.
Methods
Data
The incidence-prevalence-mortality
model uses as input the number of patients
discharged with the diagnosis of acute coro-
nary event (International Classification of
Diseases [ICD] codes 410-411) by age, sex,
period (1980-1993), and outcome (fatal or
nonfatal), and the number of deaths accord-
ing to the vital statistics by age, sex, period,
and cause of death.3 The hospital register is
used nationwide, and in nearly all recognized
cases of acute CHD the patient is hospital-
ized.67 The causes of death considered are
acute CHD (ICD codes 410-411), chronic
CHD (ICD codes 412-414), other cardiovas-
cular disease (ICD codes 390-409;
415-459), and all other causes of death. Age-
and sex-specific rates were calculated by
using the midyear population of the Nether-
lands as person-years, and rates and ratios
were age-adjusted to the average Dutch pop-
ulation of 1980 to 1993.
Model
Figure 1 illustrates the concept. A life
table population is subject to an incidence of
acute coronary events and a risk of dying
from cardiovascular disease other than CHD.
Patients experiencing an acute coronary
event who die before or after admission to
the hospital are counted as having acute
coronary death or fatal outcome. If they sur-
vive, they move to a second stage, the popu-
lation with a history of an acute coronary
event. Here they are subject to a risk of
recurrent acute coronary events, a risk of
dying from late CHD, and an increased risk
of dying from other cardiovascular diseases.
Ifthey survive, they move to a third life table
stage, the population with a history of multi-
ple infarctions. Here they are subject to an
increased risk of recurrence, death from
CHD, or death from cardiovascular disease.
In all stages, healthy or diseased, the life
table population remains exposed to a risk of
dying from noncardiovascular causes.
TIhe life table estimates an incidence by
calculating back from the observed attack
and mortality rates and from the estimated
probabilities of recurrence. These are the
core assumptions of the calculations:
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1. A history of coronary disease
increases the risk of new CHD events and of
other cardiovascular disease.8
2. Survival after a recurrent event is
less certain than after the first event.9"10
3. Survival is heavily age dependent.9
4. Survival, compared with that of a
reference population, improves over time.8"10
By applying Dutch population data to
the age-, sex-, and period-specific life table
event rates, we calculated expected numbers
and minimized the variance between the
expected and observed numbers of events
with this model. We compared expected
prevalences with the observed prevalences in
the Rotterdam study,II and we calculated
ranges using sensitivity analysis, with varying
recurrence probabilities within plausible
boundaries. A full description of all assump-
tions and of the probabilities used is available
in an appendix to this article at our Internet
website (http://www.eur.nl/fgg/mgz/); a
spreadsheet sample of the multistage life table
is available from the first author on request.
Results
Table 1 and Figure 2 present input and
results. Age-standardized admission rates
increased between 1980-1983 and
1990-1993 by 28% among women and by
9% among men, but they decreased slightly
among younger men (-6%). Mortality rates
declined by 26% and 30%, respectively, with
an even more pronounced decline among
younger men.
The estimated age-standardized inci-
dence of first acute coronary events
changed little between 1980-1983 and
1990-1993; among younger men (<60
years), this incidence decreased by 10%
(range: -14% to -6%), but among younger
women (<60 years), this incidence
increased by 9% (range: 5% to 13%). The
higher admission rates are almost entirely
attributable to the lower mortality, which in
turn is almost entirely the result of improv-
ing prognosis; the change in incidence is
negligible.
The average prevalence in survivors
increased sharply, predominantly among the
elderly: from 12% in the early 1980s to 16%
in the early 1990s in men older than 60
years and from 3.3% to 5.5% in women
older than 60 years. Over 10 years, the
absolute number of survivors increased by
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Note. Boxes show the prevalent stages, and arrows show the transition probabilities.
Three stages ("healthy," a history of 1 acute coronary event ["ACE"], and a history
of more than 1 event ["recurrence"]) are considered in 2 periods (within the first
year of discharge or more than 1 year after discharge). Transition probabilities are
specified by sex, 5-year age groups, stage, and period. Events can be nonfatal or
fatal, leading to sudden death (before admission) or to death in the hospital (after
admission).
FIGURE 1-Coronary heart disease (CHD) multistage life table model: the
Netherlands, 1980-1993.
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TABLE 1-Coronary Heart Disease (CHD) in the Netherlands, 1980-1983 and 1990-1993
Men
1980-1983 1990-1993 Change From 1980-1983
(16.8 Million Person-Years) (19.4 Million Person-Years) to 1990-1993, %
No. Rates No. Rates No. Rates
Observed
Discharges
25-59 y 38 608 2.95 42 190 2.77 9.3 -6.1
60-84y 45 263 12.21 63 543 15.00 40.4 22.9
Deaths
25-59y 11 048 0.85 7306 0.48 -33.9 -43.2
60-84y 43603 11.76 37269 8.80 -14.5 -25.2
Attacks
25-59 y 45 831 3.51 46 845 3.08 2.2 -12.2
60-84y 71 433 19.27 84184 19.88 17.9 3.2
Change From 1980-1983
to 1990-1993, %
Rates (Sensitivity Limits) Rates (Sensitivity Limits) No. Rates
Estimated
Incidence
25-59 y 2.92 (2.86, 2.98) 2.62 (2.56, 2.68) 4.6 -10.1
60-84 y 14.9 (14.5,15.4) 15.8 (15.2,16.5) 21.2 6.1
Prevalence
25-59 y 18.0 (17.6, 18.4) 17.7 (17.4, 18.1) 14.8 -1.3
60-84 y 122.2 (116.2,128.5) 157.5 (150.2,165.3) 47.3 29.0
Women
1980-1983 1990-1993 Change From 1980-1983
(17.6 Million Person-Years) (20.2 Million Person-Years) to 1990-1993, %
No. Rates No. Rates No. Rates
Observed
Discharges
25-59 y 6 981 0.57 9 793 0.66 40.3 15.9
60-84y 18218 5.08 27468 6.77 50.8 33.2
Deaths
25-59 y 2 167 0.18 1 727 0.12 -20.3 -34.1
60-84y 18743 5.73 15587 4.35 -16.8 -24.1
Attacks
25-59 y 8 384 0.68 10 893 0.73 29.9 7.4
60-84 y 29 168 8.44 36 012 9.16 23.5 8.6
Change From 1980-1983
to 1990-1993, %
Rates (Sensitivity Limits) Rates (Sensitivity Limits) No. Rates
Estimated
Incidence
25-59 y 0.56 (0.55, 0.57) 0.61 (0.60, 0.62) 26.3% 9.4%
60-84 y 6.89 (6.79, 7.01) 7.16 (6.96, 7.39) 18.0% 3.9%
Prevalence
25-59 y 3.10 (3.04, 3.16) 3.89 (3.81, 3.98) 45.1% 25.7%
60-84 y 33.2 (31.8, 34.8) 55.3 (53.0, 57.9) 89.2% 66.6%
Note. Discharges (with diagnosis of acute coronary event), deaths (CHD death in vital statistics), and attacks (the sum of fatal and nonfatal
events) are observed. Rates are per 1000 person-years, age standardized to the population of 1980-1993. The years lived by the coronary
event-free population (incidence) or by the total population (all other rates) are the denominators. Confidence limits (not shown) are very
small; the sensitivity limits are obtained by varying the recurrence probabilities within plausible upper and lower limits (see text).
36% for men and by 81% for women
because of the lower coronary mortality and
the aging of the population.
Discussion
The incidence-prevalence-mortality
model combines available administrative
data about admission rates and death rates
with parsimonious assumptions in a station-
ary multistage model to calculate expected
prevalences for patients with a history of a
single or a recurrent acute coronary event.
The results show increased heart disease
morbidity in the recent past in the Nether-
lands; that is, the expected incidence has
remained nearly constant, but mortality has
declined rapidly. Patients surviving to older
ages fill the gap between constant incidence
and decreasing mortality, given that they
are at risk for further coronary and other
cardiovascular disease. As a result, the
nation's health care needs are rising.
These results might be biased by the
nature of the data or by the assumptions
made to complete the model. Although we
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used administrative data, there were no
financial incentives to register a particular
diagnosis, and trends in the myocardial
infarction rates in such administrative hos-
pital register data compare well with trends
in epidemiological studies.12 Registration as
"acute coronary event" depends on the
patient's awareness and the doctor's diag-
nostic acuity and ability to decide between
competing choices. Indeed, it is likely that
the increased awareness of the fact that
women are also at risk for CHD is partly
attributable to the increase in clinical inci-
dence.7'3"4 Among men, however, aware-
ness has been high, and admission rates
correspond well with epidemiological event
rates.7
Is there ancillary evidence that the true
incidence ofCHD has changed? Surveys of
risk factors in the Netherlands show little
change over this period.'5 However, the
post-World War II female birth cohorts
took up smoking in large numbers and are
now arriving at middle age. The increased
detection of more benign cases and the
evolving smoking epidemic among women
of the baby boom generation suggest a true
increase in the incidence of CHD. Several
epidemiological studies have researched
CHD mortality in the developed world in
relation to the improved treatment options
available. 0 16,17 Because many survivors
will lead satisfactory lives, this marks a tri-
umph in modem (heart) health care. How-
ever, the marked decline of mortality has
resulted in large pools ofCHD survivors; as
a result, combined with the aging of the
population, health care needs are increasing
sharply. LI
Contributors
All 3 authors contributed substantially to the concep-
tion and design ofthe study and to inteipretation ofthe
data. L. Bonneux analyzed the data and implemented
the multistage lifetables. J. J. Barendregt constructed
these tables and verified their correct use.
L. Bonneux drafted the paper, and J. J. Barendregt and
P. J. van der Maas made comments on it. All are guar-
antors for the integrity of the study.
Acknowledgments
This study was funded by the Netherlands Heart
Foundation and the Netherlands Organization for
Scientific Research.
The authors are grateful to J. Reitsma of the
University ofAmsterdam for extraction of the data.
References
1. Murray CJL, Lopez AD. Mortality by cause for
eight regions of the world: Global Burden of
Disease Study. Lancet. 1997;349:1269-1276.
2. Polder J, Meerding JW, Koopmanschap MA,
Bonneux L, van der Maas P. Costs ofDiseases
in 1994 [in Dutch]. Rotterdam, the Nether-
lands: Department of Public Health; 1997.
3. Bonneux L, Looman CW, Barendregt JJ, van der
Maas PJ. Regression analysis of recent changes
in cardiovascular morbidity and mortality in The
Netherlands. BMJ. 1997;314:789-792.
4. Bonneux L, Barendregt JJ, Meeter K, Bonsel
GJ, van der Maas PJ. Estimating clinical mor-
bidity due to ischemic heart disease and con-
gestive heart failure: the future rise of heart
failure. Am JPublic Health. 1994;84:20-28.
5. Murray CJL, Lopez AD. Global and regional
descriptive epidemiology of disability. In: Mur-
ray CJL, Lopez AD, eds. The Global Burden of
Disease and Injury Series. Boston, Mass: Har-
vard University Press; 1996:201-246.
6. Fracheboud J. Coronary Center Care or Home
Care? A Descriptive Study ofHome Care of
Patients With an Acute Myocardial Infarction
in the Netherlands [in Dutch]. Utrecht, the
Netherlands: NIVEL; 1987.
7. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P,
Arveiler D, Rajakangas AM, Pajak A. Myocar-
dial infarction and coronary deaths in the
World Health Organization MONICA Project.
Registration procedures, event rates, and case-
fatality rates in 38 populations from 21 coun-
tries in four continents. Circulation. 1994;
90:583-612.
8. Kannel WB, Sorlie P, McNamara PM.
Prognosis after initial myocardial infarc-
tion: the Framingham study. Am J Cardiol.
1979;44:53-59.
9. Ahnve S, Gilpin E, Dittrich H, et al. First
myocardial infarction: age and ejection fraction
identify a low-risk group. Am Heart J. 1988;
116:925-932.
10. McGovern PG, Pankow JS, Shahar E, et al.
Recent trends in acute CHD-mortality, mor-
bidity, medical care, and risk factors. N Engl J
Med. 1996;334:884-890.
11. Grobbee DE, van der Bom JG, Bots ML, de
Bruijne MC, Mosterd A, Hoes AW. CHD in the
elderly; the ERGO study [in Dutch]. Ned Trd-
schr Geneeskd. 1995;139:1978-1982.
12. Mahonen M, Miettinen H, Pyorala K, Molarius
A, Salomaa V, Kuulasmaa K. Hospital discharge
register data in the assessment of trends in acute
myocardial infarction. FINMONICA AMI Reg-
ister Study Team. Ann Med. 1995;27:547-554.
13. Khaw KT. Where are the women in studies of
CHD? BMJ. 1993;306: 1145-1146.
14. Healy B. The Yentl syndrome. N Engl J Med.
1991;325:274-276.
15. Ruwaard D, Kramers PGN, Van den Bergh
Jeths A, Achterberg PW. Public Health Status
of the Dutch Population Over the Period
1950-2010. The Hague, the Netherlands:
SDU; 1994.
16. Sytkowski PA, Kannel WB, D'Agostino RB.
Changes in risk factors and the decline in mortal-
ity from cardiovascular disease. The Framing-
ham Heart Study. N Engl J Med. 1990;322:
1635-1641.
17. Torp-Pedersen C, Hildebrandt P, Kober L, et al.
Improving long-term survival of patients
with acute myocardial infarction from 1977-
1988 in a region of Denmark. Eur Heart J.
1995;16:14-20.
382 American Journal of Public Health March 1999, Vol. 89, No. 3
